Pharmaceutical

Emergent seeking to reverse fortunes and become a major overdose treatment player

Emergent Biosolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose treatment portfolio, which includes Narcan.

Jan 24, 2025 - 06:00
Emergent seeking to reverse fortunes and become a major overdose treatment player
Emergent Biosolutions (Gaithersburg, US) has purchased US and Canadian rights to Kloxxado, adding to its opioid overdose treatment portfolio, which includes Narcan.
Read the original article

Tags:

Previous Article

FDA grants ODD status to Zai Lab’s lung cancer treatment

Next Article

Disc raises $225.5m as it eyes approval of rare skin disorder drug  

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: A new startup looks to turn the workhorse of gene therapy against cancer

STAT+: A new startup looks to turn the workhorse of gen...

May 17, 2023

Here’s what’s moving the needle in biotech stocks, in the final quarter of a dismal year

Here’s what’s moving the needle in biotech stocks, in t...

Oct 2, 2023

City Therapeutics launches with $135m Series A funding

City Therapeutics launches with $135m Series A funding

Oct 10, 2024